Literature DB >> 27995345

Interpretation of the Elecsys Toxo IgG avidity results for very low and very high index: study on 741 sera with a determined date of toxoplasmosis.

H Fricker-Hidalgo1, C L'Ollivier2, C Bosson3, S Imbert4, S Bailly3, C Dard3, R Piarroux2, L Paris4, H Pelloux3.   

Abstract

Initial results with the Elecsys Toxo IgG Avidity assay showed some potential for interpretation of a very low or very high index result. We aimed to examine these new insights into interpretation using a large panel of serum samples and to define the optimal thresholds. A total of 741 patient serum samples with known date of infection (from a few weeks to more than 9 months after infection), were analysed with the Elecsys Toxo IgG Avidity assay. Values ≥80% (threshold defined by the manufacturer) were reported in 289 sera; 288 sera were sampled more than 4 months after infection. Thus, avidity values ≥80% excluded an infection less than 4 months. Avidity values ≥90% were reported in 112 sera sampled more than 9 months after infection. Thus, avidity values ≥90% excluded infection less than 9 months. Moreover avidity values ≤15% were reported in the 62 sera sampled less than 3 months after infection. Thus avidity values ≤15% excluded infection more than 3 months.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27995345     DOI: 10.1007/s10096-016-2870-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

1.  Comparative evaluation of the ARCHITECT Toxo IgG, IgM, and IgG Avidity assays for anti-Toxoplasma antibodies detection in pregnant women sera.

Authors:  Françoise Gay-Andrieu; Hélène Fricker-Hidalgo; Eva Sickinger; Anne Espern; Marie-Pierre Brenier-Pinchart; Hans-Bertram Braun; Hervé Pelloux
Journal:  Diagn Microbiol Infect Dis       Date:  2009-11       Impact factor: 2.803

2.  A new human IgG avidity test, using mixtures of recombinant antigens (rROP1, rSAG2, rGRA6), for the diagnosis of difficult-to-identify phases of toxoplasmosis.

Authors:  Dorota Drapała; Lucyna Holec-Gąsior; Józef Kur; Bartłomiej Ferra; Elżbieta Hiszczyńska-Sawicka; Dariusz Lautenbach
Journal:  Diagn Microbiol Infect Dis       Date:  2014-03-17       Impact factor: 2.803

3.  Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux).

Authors:  H Pelloux; E Brun; G Vernet; S Marcillat; M Jolivet; D Guergour; H Fricker-Hidalgo; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  Diagn Microbiol Infect Dis       Date:  1998-10       Impact factor: 2.803

4.  Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results.

Authors:  Jean-Benjamin Murat; Coralie L'Ollivier; Hélène Fricker Hidalgo; Jacqueline Franck; Hervé Pelloux; Renaud Piarroux
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

5.  Congenital Toxoplasmosis.

Authors:  James B McAuley
Journal:  J Pediatric Infect Dis Soc       Date:  2014-09       Impact factor: 3.164

6.  Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States.

Authors:  Reshika Dhakal; Kiran Gajurel; Christelle Pomares; Jeanne Talucod; Cynthia J Press; Jose G Montoya
Journal:  J Clin Microbiol       Date:  2015-09-09       Impact factor: 5.948

Review 7.  Epidemiology of and diagnostic strategies for toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Laure Dardé
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

8.  Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study.

Authors:  H Fricker-Hidalgo; B Cimon; C Chemla; M L Darde; L Delhaes; C L'ollivier; N Godineau; S Houze; L Paris; D Quinio; F Robert-Gangneux; O Villard; I Villena; E Candolfi; H Pelloux
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

Review 9.  Management of Toxoplasma gondii infection during pregnancy.

Authors:  Jose G Montoya; Jack S Remington
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

10.  Value of 2 IgG avidity commercial tests used alone or in association to date toxoplasmosis contamination.

Authors:  Laurence Lachaud; Olivier Calas; Marie Christine Picot; Sahar Albaba; Nathalie Bourgeois; Francine Pratlong
Journal:  Diagn Microbiol Infect Dis       Date:  2009-04-22       Impact factor: 2.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.